Company Profile - Xenetic Biosciences Inc

Introduction

Xenetic Biosciences Inc (Xenetic Biosciences), formerly General Sales & Leasing Inc, is a biopharmaceutical company. It discovers and develops biologic drugs and novel orphan oncology therapeutics. Its pipeline products include Virexxa, ErepoXen, and OncoHist. Xenetic Biosciences' lead product candidate ErepoXen is a polysialylated form of erythropoietin used to treat anemia in pre-dialysis patients with chronic kidney disease. The company’s Virexxa and OncoHist are used for the treatment of progesterone receptor negative endometrial cancer and refractory acute myeloid leukemia. It also provides biologic drugs and innovative orphan cancer drugs. The company has operations in the US and the UK. Xenetic Biosciences is headquartered in Lexington, Massachusetts, the US.